PMC full text:
Published online 2024 Oct 3. doi: 10.5144/0256-4947.2024.306
Table 2.
Mortality data of COVID-19 PCR positive patients before 31 August 2021 and after 1 September 2021 setting the beginning of nationwide vaccination of pregnant patients.
| Mortality | Pre-vaccination period (before 31 August 2021) n=13 | Post-vaccination period (after 1 September 2021) n=9 | P value |
|---|---|---|---|
| Age | 33.23 (5.08) | 29 (6.02) | .090 |
| Gravidity | 2.0 (1.0-2.0) | 1.0 (0.0-2.5) | .149 |
| Parity | 1 (0.25-3.0) | 1.0 (0.25-2.0) | .334 |
| Gestational week | 31.92 (3.73) | 32.33 (3.7) | .788 |
| APGAR 1’ score | 6.0 (1.0-7.5) | 7.0 (3.0-8.0) | .154 |
| APGAR 5’ score | 8.0 (5.5-8.0) | 9.0 (6.0-9.0) | .169 |
| Indication placental anomaly | 0 | 0 | >.99 |
| Indication presentation anomaly/CPD | 1 (7.7) | 0 | .405 |
| Indication fetal distress | 5 (38.5) | 1 (11.1) | .166 |
| Indication maternal ARDS | 6 (46.2) | 1 (11.1) | .045 |
| Indication previous uterine surgery | 1 (11.1) | 0 | .405 |
| Additional chronic disease malignancy | 0 | 0 | >.99 |
| Additional chronic thyroid disease | 2 (15.4) | 0 | .228 |
| Additional chronic diabetes | 1 (7.7) | 3 (33.3) | .134 |
| Additional chronic respiratory disorder | 0 | 0 | >.99 |
| Additional chronic hypertensive disorder | 1 (7.7) | 0 | .405 |
| Vaccinated patient | 0 | 0 | >.99 |
| Variant | 2 (Delta variant) (15.4) | 0 | .228 |
| ICU administration | 13 (100) | 9 (100) | >.99 |
Results are presented as mean (SD) for normally distributed data, median (25-75 percentile) for non-normally distributed data. Number (percentage) for categorical variables. To compare independent categorical variables. The chi-square test was applied. CPD: cephalo-pelvic disproportion; ARDS: acute respiratory distress syndrome.